Transitory decrease of platelet count, aggregation and adhesion after plasmapheresis and immunosorption procedures.
Mazurov
A V
AV
Cardiology Research Center, Moscow, USSR.
Sinitsyn
V E
VE
Khashimov
Kh A
KhA
Konovalov
G A
GA
Vedernikov
A V
AV
Repin
V S
VS
D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; D000328:Adult; D001792:Blood Platelets / Q000502:physiology*; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood* / Q000628:therapy; D007163:Immunosorbent Techniques; D008077:Lipoproteins, LDL / Q000302:isolation & purification; D008297:Male; D008875:Middle Aged; D010956:Plasmapheresis; D010973:Platelet Adhesiveness; D010974:Platelet Aggregation / Q000187:drug effects; D010976:Platelet Count; D011450:Prostaglandin Endoperoxides, Synthetic / Q000494:pharmacology; D013997:Time Factors
D008077:Lipoproteins, LDL; D011450:Prostaglandin Endoperoxides, Synthetic; D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid